Zynex, Inc. (NASDAQ: ZYXI) (“Zynex”, “ZMS”, “we” or the “Company”), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain management, rehabilitation, and patient monitoring, today announced a new partnership to conduct business with Veterans Affairs Medical Centers (VAMCs) across the United States. This collaboration reflects Zynex’s commitment to improving access to high-quality care for our nation’s veterans.
It is estimated that the VA spends over $112 billion annually on healthcare. This partnership enables Zynex to bring its advanced pain management solutions to a critical and growing market, with the VA’s system alone servicing over 9 million enrolled veterans. Currently, less than 1% of Zynex’s sales are from VAMCs and the partnership provides an opportunity to significantly expand sales into the largest healthcare network in the U.S.
With 171 VAMCs and over 1,100 outpatient facilities nationwide, the Department of Veterans Affairs serves millions of veterans annually. Additionally, there are approximately 700 Military Treatment Facilities (MTFs) operated by the Department of Defense, forming an extensive network for addressing the healthcare needs of service members and their families.
“Our partnership to do business with the VA represents a significant milestone in expanding access to non-opioid pain management solutions for those who have served our country,” said Thomas Sandgaard, CEO, Founder, and Chairman. “Working with the VA provides us with access to the largest healthcare network in the United States and we are honored to help enhance the quality of care for veterans nationwide.”
As part of this collaboration, Zynex’s sales team will work closely with healthcare providers within the VA and MTF networks to deliver its full product suite of innovative, pain management treatments designed to improve patient outcomes while addressing the unique pain management needs of these populations.
